Search

Charles Rowland Phones & Addresses

  • Copperopolis, CA
  • 22082 El Coyote Dr, Sonora, CA 95370 (209) 533-1916
  • Thousand Oaks, CA
  • Danville, CA
  • East Bridgewater, MA
  • San Ramon, CA

Professional Records

Lawyers & Attorneys

Charles Rowland Photo 1

Charles W. Rowland - Lawyer

View page
Licenses:
Texas - Eligible To Practice In Texas 1969
Education:
Hastings College of Law (U. of Calif.)
Degree - Doctor of Juridical Science
Graduated - 1966
Charles Rowland Photo 2

Charles Rowland - Lawyer

View page
Specialties:
Civil Litigation
Government
Civil Rights Defense
Medical Malpractice Defense
ISLN:
1000165062
Admitted:
2014

Medicine Doctors

Charles Rowland Photo 3

Charles F. Rowland

View page
Specialties:
Orthopaedic Surgery
Work:
Maple Leaf Orthopedics
3530 E Spaulding Ave, Pueblo, CO 81008
(719) 296-9000 (phone), (719) 296-9001 (fax)
Education:
Medical School
University of Texas Medical School at San Antonio
Graduated: 1971
Procedures:
Hallux Valgus Repair
Lower Leg Amputation
Lower Leg/Ankle Fractures and Dislocations
Arthrocentesis
Carpal Tunnel Decompression
Hip Replacement
Hip/Femur Fractures and Dislocations
Knee Arthroscopy
Knee Replacement
Lower Arm/Elbow/Wrist Fractures and Dislocations
Occupational Therapy Evaluation
Shoulder Surgery
Spinal Fusion
Spinal Surgery
Conditions:
Fractures, Dislocations, Derangement, and Sprains
Internal Derangement of Knee Cartilage
Hallux Valgus
Internal Derangement of Knee
Intervertebral Disc Degeneration
Languages:
English
Spanish
Description:
Dr. Rowland graduated from the University of Texas Medical School at San Antonio in 1971. He works in Pueblo, CO and specializes in Orthopaedic Surgery. Dr. Rowland is affiliated with Parkview Medical Center.
Charles Rowland Photo 4

Charles Rowland

View page
Specialties:
Congenital Cardiac Surgery (Thoracic Surgery)
Work:
Jefferson University PhysiciansJefferson University Physicians Cardiothoracic Surgery
1025 Walnut St STE 607, Philadelphia, PA 19107
(215) 955-6996 (phone), (215) 955-6010 (fax)
Languages:
English
Spanish
Description:
Mr. Rowland works in Philadelphia, PA and specializes in Congenital Cardiac Surgery (Thoracic Surgery). Mr. Rowland is affiliated with Einstein Medical Center Of Philadelphia and Thomas Jefferson University Hospital.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Charles Rowland
President
Vci Visual Communication
Communication Services
4370 Sandmound Blvd, Oakley, CA 94561
Charles Rowland
President
Santino's Pizza Parlor Inc
Eating Place
4231 Telegraph Rd, Ventura, CA 93003
(805) 644-0166
Charles Matthew Rowland
President
ROWLAND MEDIA, INC
Communication Services
6524 Grn Castle Crk, Discovery Bay, CA 94505
6524 Grn Castle Cir, Discovery Bay, CA 94505
Charles A. Rowland
Director
BIND Therapeutics
Biotechnology · Noncommercial Research Organization
325 Vassar St, Cambridge, MA 02139
64 Sidney St, Cambridge, MA 02139
101 Binney St, Cambridge, MA 02142
(617) 491-3400, (617) 491-0351
Charles N Rowland
C N R RETIREMENT FUND, LLC
Charles R. Rowland
SCHAEFER & CO
Charles H. Rowland
President
Golden Hills Enterprises Inc
Insurance Agent/Broker
427 Hwy 49, Sonora, CA 95370
PO Box 3044, Sonora, CA 95370
Charles D Rowland
President
STARLIGHT ALASKA INC

Publications

Us Patents

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
7695916, Apr 13, 2010
Filed:
Mar 21, 2008
Appl. No.:
12/077935
Inventors:
Olga Iakoubova - San Ramon CA, US
James Devlin - Lafayette CA, US
Charles Rowland - San Leandro CA, US
Carmen Tong - Dublin CA, US
Assignee:
Celera Corporation - Alameda CA
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 6, 435 911, 435 912
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
8148070, Apr 3, 2012
Filed:
Sep 29, 2009
Appl. No.:
12/569475
Inventors:
Olga Iakoubova - San Ramon CA, US
James J. Devlin - Lafayette CA, US
Carmen Tong - Dublin CA, US
Charles Rowland - San Leandro CA, US
Assignee:
Celera Corporation - Alameda CA
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 61, 435 611, 435 612
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Composite Metastasis Score With Weighted Coefficients For Predicting Breast Cancer Metastasis, And Uses Thereof

View page
US Patent:
8557525, Oct 15, 2013
Filed:
Feb 27, 2012
Appl. No.:
13/406221
Inventors:
Alice Wang - Lafayette CA, US
Robert J. Lagier - San Leandro CA, US
Charles M. Rowland - San Francisco CA, US
Assignee:
Celera Corporation - Alameda CA
International Classification:
C12Q 1/68
US Classification:
435 614, 435 912, 435194, 536 243, 536 2433
Abstract:
The present invention relates to a composite metastasis score (“cMS”) based on expression of a 14-gene molecular signature (referred to as a metastasis score, or “MS”) in combination with progesterone receptor (PR) expression that is useful for predicting breast cancer metastasis. In preferred embodiments, the cMS is determined by applying weighted coefficients to MS and PR. The present invention provides methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information for predicting risk of breast cancer metastasis, among other embodiments.

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
20130058914, Mar 7, 2013
Filed:
Feb 28, 2012
Appl. No.:
13/407501
Inventors:
Olga IAKOUBOVA - San Ramon CA, US
James DEVLIN - Lafayette CA, US
Charles ROWLAND - San Leandro CA, US
Carmen TONG - Dublin CA, US
Assignee:
CELERA CORPORATION - ALAMEDA CA
International Classification:
C12Q 1/68
A61K 31/7088
A61K 38/02
A61K 39/395
US Classification:
4241301, 435 611, 514 44 A, 514 11
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
20140072550, Mar 13, 2014
Filed:
Jun 27, 2013
Appl. No.:
13/929136
Inventors:
James J. DEVLIN - Lafayette CA, US
Carmen TONG - Dublin CA, US
Charles ROWLAND - San Leandro CA, US
Assignee:
CELERA CORPORATION - Alameda CA
International Classification:
C12Q 1/68
US Classification:
4241301, 435 611, 514423, 514548
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
20200123610, Apr 23, 2020
Filed:
Aug 28, 2019
Appl. No.:
16/553592
Inventors:
- San Juan Capistrano CA, US
James J. DEVLIN - Lafayette CA, US
Carmen TONG - Dublin CA, US
Charles ROWLAND - San Leandro CA, US
International Classification:
C12Q 1/6883
G01N 33/68
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Genetic Polymorphisms Associated With Coronary Events And Drug Response, Methods Of Detection And Uses Thereof

View page
US Patent:
20170022563, Jan 26, 2017
Filed:
May 10, 2016
Appl. No.:
15/150636
Inventors:
- San Clemente CA, US
James J. DEVLIN - Lafayette CA, US
Carmen TONG - Dublin CA, US
Charles ROWLAND - San Leandro CA, US
International Classification:
C12Q 1/68
G01N 33/68
Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Isbn (Books And Publications)

Hutley's Australian Wills Precedents

View page
Author

Charles Rowland

ISBN #

0409303216

Hutley's Australian Wills Precedents

View page
Author

Charles Rowland

ISBN #

0409307335

Hutley's Australian Wills Precedents

View page
Author

Charles Rowland

ISBN #

0409310581

Hutley's Australian Wills Precedents

View page
Author

Charles Rowland

ISBN #

0409494887

Charles Howard Rowland from Copperopolis, CA, age ~68 Get Report